FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2335319317> ?p ?o ?g. }

• W2335319317 endingPage "409" @default.
• W2335319317 startingPage "408.4" @default.
• W2335319317 abstract "<h3>Background</h3> Cardiovascular risk (CVR) is increased in RA and should be evaluated annually. EULAR recommends using the SCORE equation to calculate risk, after applying a multiplier of 1.5 in patients with RA who meet two of the following three criteria: disease duration >10 years, rheumatoid factor or anti-CCP antibody positivity, presence of extra-articular manifestations. European guidelines recommend statin therapy for subjects with high or very high risk i.e patients aged 45-65 years when CVR calculated with the SCORE equation is ≥10% and LDL-cholesterol is ≥1.8 mmol/l, or when CVR is >5% and <10% and LDL-cholesterol is ≥2.5 mmol/l. American recommendations have recently changed and a new equation to assess overall CVR has been validated. Statin therapy is recommended for subjects aged 40-75 years when CVR is ≥7.5%. According to both European and American recommendations, all patients with prior cardiovascular events (myocardial infarction (MI), stroke, lower limb arteriopathy) and all diabetic patients should receive statins. <h3>Objectives</h3> Assess the need for statin treatment in an established RA cohort (COMEDRA study) according to European and American recommendations with and without application of the multiplier proposed by EULAR, in patients aged 45-65 years, in order to compare the two sets of recommendations; and assess statin prescription in RA as secondary prevention or in diabetic patients. <h3>Methods</h3> The COMEDRA study evaluated the impact of a nurse consultation on the management of comorbidities of RA. All patients in this study had a lipid workup and all CVR factors were noted. <h3>Results</h3> 620 patients (79.8% women) with established RA (mean disease duration 13.2±9.9 years) were analyzed. RA was erosive in 447 (73%) and 524 (84.6%) had positive RF or anti-CCP antibodies. 450 patients (72.9%) were treated with a biologic and 223 (36%) received glucocorticoids (mean, 5.5±5.6 mg/day). One hundred (16.1%) patients had a family history of early onset CV disease, 155 (15%) were treated for hypertension, 110 (17.7%) were on lipid lowering drugs, 136 (21.9%) had BP >140/90, 124 (20%) were smokers. 7 (1%) patients had prior MI, 15 (2.4%) had prior stroke and 6 (1%) had lower limb arteriopathy. 33 (5.3%) patients were diabetic. According to European recommendations, 13 should receive statins, of whom 6 (46%) were treated and by applying EULAR recommendations 17 should receive statins, of whom 10 (59%) were treated. According to American recommendations, 150 should receive statins, of whom 32 (46%) were treated and by applying the same multiplier of 1.5, 234 should receive statin, of whom 45 (59%) were treated. Only 8/28 (28.5%) patients in secondary prevention and 11/33 (33.3%) of diabetic patients received a statin. <h3>Conclusions</h3> According to the recommendation used, the number of RA patients requiring statin varies by a factor 10. More information is needed on which recommendation set performs best for prediction of long-term outcomes. <h3>Disclosure of Interest</h3> None declared <h3>DOI</h3> 10.1136/annrheumdis-2014-eular.5112" @default.
• W2335319317 created "2016-06-24" @default.
• W2335319317 creator A5009452487 @default.
• W2335319317 creator A5010814818 @default.
• W2335319317 creator A5013394355 @default.
• W2335319317 creator A5062958039 @default.
• W2335319317 creator A5077099389 @default.
• W2335319317 creator A5091895459 @default.
• W2335319317 date "2014-06-01" @default.
• W2335319317 modified "2023-09-24" @default.
• W2335319317 title "FRI0076 Need for Statins in Rheumatoid Arthritis Patients with High Cardiovascular Risk: Differences According to European and American Recommendations. the Comedra Study" @default.
• W2335319317 doi "https://doi.org/10.1136/annrheumdis-2014-eular.5112" @default.
• W2335319317 hasPublicationYear "2014" @default.
• W2335319317 type Work @default.
• W2335319317 sameAs 2335319317 @default.
• W2335319317 citedByCount "0" @default.
• W2335319317 crossrefType "journal-article" @default.
• W2335319317 hasAuthorship W2335319317A5009452487 @default.
• W2335319317 hasAuthorship W2335319317A5010814818 @default.
• W2335319317 hasAuthorship W2335319317A5013394355 @default.
• W2335319317 hasAuthorship W2335319317A5062958039 @default.
• W2335319317 hasAuthorship W2335319317A5077099389 @default.
• W2335319317 hasAuthorship W2335319317A5091895459 @default.
• W2335319317 hasConcept C126322002 @default.
• W2335319317 hasConcept C1862650 @default.
• W2335319317 hasConcept C2426938 @default.
• W2335319317 hasConcept C2776839432 @default.
• W2335319317 hasConcept C2777575956 @default.
• W2335319317 hasConcept C500558357 @default.
• W2335319317 hasConcept C71924100 @default.
• W2335319317 hasConcept C72563966 @default.
• W2335319317 hasConcept C98274493 @default.
• W2335319317 hasConceptScore W2335319317C126322002 @default.
• W2335319317 hasConceptScore W2335319317C1862650 @default.
• W2335319317 hasConceptScore W2335319317C2426938 @default.
• W2335319317 hasConceptScore W2335319317C2776839432 @default.
• W2335319317 hasConceptScore W2335319317C2777575956 @default.
• W2335319317 hasConceptScore W2335319317C500558357 @default.
• W2335319317 hasConceptScore W2335319317C71924100 @default.
• W2335319317 hasConceptScore W2335319317C72563966 @default.
• W2335319317 hasConceptScore W2335319317C98274493 @default.
• W2335319317 hasIssue "Suppl 2" @default.
• W2335319317 hasLocation W23353193171 @default.
• W2335319317 hasOpenAccess W2335319317 @default.
• W2335319317 hasPrimaryLocation W23353193171 @default.
• W2335319317 hasRelatedWork W2082406232 @default.
• W2335319317 hasRelatedWork W2105039597 @default.
• W2335319317 hasRelatedWork W2156283049 @default.
• W2335319317 hasRelatedWork W2316954211 @default.
• W2335319317 hasRelatedWork W2326094713 @default.
• W2335319317 hasRelatedWork W2367140913 @default.
• W2335319317 hasRelatedWork W2427075784 @default.
• W2335319317 hasRelatedWork W2427452099 @default.
• W2335319317 hasRelatedWork W2761967325 @default.
• W2335319317 hasRelatedWork W4245782456 @default.
• W2335319317 hasVolume "73" @default.
• W2335319317 isParatext "false" @default.
• W2335319317 isRetracted "false" @default.
• W2335319317 magId "2335319317" @default.
• W2335319317 workType "article" @default.